Impact of Raloxifene or Tamoxifen Use on Endometrial Cancer Risk: A Population-Based Case-Control Study

PURPOSE: Raloxifene reduces breast cancer risk in women with osteoporosis, and both tamoxifen and raloxifene prevent breast cancer in high-risk women. However, in vitro, raloxifene does not share the pro-estrogenic effects of tamoxifen on the endometrium. Randomized trials of these agents have provi...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
मुख्य लेखकों: DeMichele, Angela, Troxel, Andrea B., Berlin, Jesse A., Weber, Anita L., Bunin, Greta R., Turzo, Elene, Schinnar, Rita, Burgh, Desiree, Berlin, Michelle, Rubin, Stephen C., Rebbeck, Timothy R., Strom, Brian L.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: American Society of Clinical Oncology 2008
विषय:
Gynecologic Cancer
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC2654370/
https://ncbi.nlm.nih.gov/pubmed/18757329
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2007.14.0921
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन